Home › Funds › ARIEL INVESTMENTS, LLC › CRL

ARIEL INVESTMENTS, LLC position in CRL

CHARLES RIV LABS INTL INC · Health Care

ARIEL INVESTMENTS, LLC reported holding 1,193,348 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$352.0M, representing 3.66% of its reported portfolio and ranking #3 among its reported holdings. ARIEL INVESTMENTS, LLC has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.19M sh
Reported value held$352.05M
Portfolio Weight3.66%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ARIEL INVESTMENTS, LLC's CRL position evolved

ARIEL INVESTMENTS, LLC first disclosed a stake in CRL in Q3 2023 at 1,066,600 shares (US$209.0M). The position peaked in Q3 2026 at 1,193,348 shares, worth US$352.0M. Across 13 filings, ARIEL INVESTMENTS, LLC increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,193,348 shares valued at US$352.0M — a reduction of -312,837 shares quarter over quarter.. Notable position changes include a 29% increase in Q2 2025 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.07M $209.03M New
Q4 2023 1.05M $248.39M Reduce
Q1 2024 932.81K $252.74M Reduce
Q2 2024 906.14K $187.19M Reduce
Q3 2024 897.69K $176.82M Reduce
Q4 2024 1.07M $197.03M Add
Q1 2025 1.10M $165.69M Add
Q2 2025 1.42M $214.75M Add
Q3 2025 1.49M $233.14M Add
Q4 2025 1.43M $284.81M Reduce
Q1 2026 1.44M $249.12M Add
Q2 2026 1.51M $341.59M Add
Q3 2026 1.19M $352.05M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRL and 13F data

CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 28 other funds we track also report a position in CRL — the largest reported positions include EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M), COOKE & BIELER LP (US$127.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRL

All CRL fund holders →

FAQ

How long has ARIEL INVESTMENTS, LLC held CRL?

ARIEL INVESTMENTS, LLC has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ARIEL INVESTMENTS, LLC's current position in CRL?

As of Q3 2026, ARIEL INVESTMENTS, LLC holds 1.19M shares of CRL (CHARLES RIV LABS INTL INC), valued at $352.05M, representing 3.66% of its reported portfolio and ranking #3.

Has ARIEL INVESTMENTS, LLC been buying or selling CRL?

In the latest 13F filing (Q3 2026), ARIEL INVESTMENTS, LLC reduced its position in CRL. The position peaked in Q3 2026 at 1.19M shares.

Which other funds hold CRL?

Other major institutional holders of CRL include EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, COOKE & BIELER LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.